TBRG · As filed with the SEC
TruBridge income statement, by fiscal year
The statement as TruBridge presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF OPERATIONS · USD thousands, except per-share amounts; shares in thousands
| USD thousands, except per-share amounts; shares in thousands | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| Revenues: | ||||
| Total revenues | 346,836 | 342,646 | 339,435 | 326,648 |
| Revenue cycle | — | — | — | 179,870 |
| Electronic health record | — | — | — | 139,823 |
| Patient engagement | — | — | — | 6,955 |
| RCM | — | — | 193,929 | — |
| EHR | — | — | 138,063 | — |
| Patient engagement | — | — | 7,443 | — |
| Financial Health | 221,657 | 217,672 | — | — |
| Patient Care | 125,179 | 124,974 | — | — |
| Expenses: | ||||
| Costs of revenue (exclusive of amortization and depreciation): | ||||
| Total costs of revenue (exclusive of amortization and depreciation) | 162,974 | 168,531 | 175,868 | 172,213 |
| Revenue cycle | — | — | — | 97,010 |
| Electronic health record | — | — | — | 71,347 |
| Patient engagement | — | — | — | 3,856 |
| Gross profit | — | — | — | 154,435 |
| RCM | — | — | 110,192 | — |
| EHR | — | — | 62,048 | — |
| Patient engagement | — | — | 3,628 | — |
| Financial Health | 113,891 | 116,891 | — | — |
| Patient Care | 49,083 | 51,640 | — | — |
| Product development | 32,557 | 34,456 | 37,246 | 30,926 |
| Sales and marketing | 23,509 | 27,059 | 28,049 | 27,131 |
| General and administrative | 80,687 | 76,992 | 76,153 | 56,192 |
| Amortization of acquisition-related intangibles | — | — | — | 17,403 |
| Total operating expenses | — | — | — | 131,652 |
| Amortization | 25,185 | 27,627 | 24,522 | — |
| Depreciation | 1,092 | 1,346 | 1,946 | — |
| Goodwill impairment | 0 | 0 | 35,913 | — |
| Trademark impairment | 0 | 0 | 2,342 | — |
| Total expenses | 326,004 | 336,011 | 382,039 | — |
| Operating income (loss) | 20,832 | 6,635 | (42,604) | 22,783 |
| Other (expense) income: | ||||
| Other income | — | — | 745 | 1,178 |
| Gain on contingent consideration | — | — | — | 565 |
| Gain on contingent consideration | — | — | 0 | — |
| Loss on extinguishment of debt | — | — | 0 | (125) |
| Interest expense | — | — | (12,521) | (6,320) |
| Interest expense | (12,316) | (16,169) | — | — |
| Other (expense) income | (4,647) | (670) | (11,776) | (4,702) |
| Total other expense | (16,963) | (16,839) | — | — |
| Income (loss) before taxes | 3,869 | (10,204) | (54,380) | 18,081 |
| (Benefit) provision for income taxes | (485) | 10,235 | (8,591) | 2,214 |
| Net income (loss) | 4,354 | (20,439) | (45,789) | 15,867 |
| Net income (loss) per share - basic (in dollars per share) | 0.29 | (1.38) | (3.15) | 1.08 |
| Net income (loss) per share - diluted (in dollars per share) | 0.29 | (1.38) | (3.15) | 1.08 |
| Weighted average shares outstanding used in per common share computations: | ||||
| Basic (in shares) | 14,488 | 14,300 | 14,187 | 14,356 |
| Diluted (in shares) | 14,488 | 14,300 | 14,187 | 14,356 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
